Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Xvivo Perfusion Major Shareholding Notification 2017

Apr 18, 2017

3130_iss_2017-04-18_360ae072-150e-4262-b453-e372aeb85f46.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Xvivo Perfusion Aktiebolag

Holder

Bure Equity AB (publ)

Instrument

Instrument AK
Before the transaction
Shares 4,891,483
Voting rights 4,891,483
Transaction
Reason for major shareholding notification New share issue
Date 13/04/2017
Limit for number of shares 20 %
Limit for number of votes 20 %
After the transaction
Quantity
Shares 4,891,483
Directly held voting rights 4,891,483
Indirectly held voting rights 0
Percentage
Directly held shares 18.8 %
Directly held voting rights 18.8 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 18.8 % 4,891,483
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 18.8 % 4,891,483
Group total holdings
Voting rights
4,891,483
Percentage of voting rights 18.8
Published
18/04/2017 17:07
Contact
Name
Max Jonson
Phone
0725087512 Email [email protected]
CLOSE
PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25